Kura Oncology (KURA) Interest Expenses (2010 - 2026)
Kura Oncology (KURA) reported Interest Expenses of $336000.0 for Q1 2026, down 12.04% year-over-year from $382000.0 in Q1 2025, and down 2.89% quarter-over-quarter from $346000.0 in Q4 2025.
Kura Oncology (KURA) Interest Expenses (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 16 years of Interest Expenses data on file, last reported at $336000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $336000.0, down 12.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 8.55% YoY), and the FY2025 annual result was $1.5 million, down 6.61% from the prior year.
- Interest Expenses slipped to $336000.0 in Q1 2026 per KURA's latest filing, from $346000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $412000.0 in Q3 2024 and troughed at $336000.0 in Q1 2026.
- A 4-year average of $385846.2 and a median of $393000.0 in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses rose 9.34% in 2024, then declined 14.14% in 2025.
- A 4-year view of Interest Expenses shows it stood at $394000.0 in 2023, then grew by 2.28% to $403000.0 in 2024, then decreased by 14.14% to $346000.0 in 2025, then dropped by 2.89% to $336000.0 in 2026.
- Business Quant data shows KURA's Interest Expenses at $336000.0 in Q1 2026, $346000.0 in Q4 2025, and $393000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336,000.00 |
| Mar 31, 2026 | 336,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 393,000.00 |
| Sep 30, 2025 | 393,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Dec 31, 2023 | 394,000.00 |
| Dec 31, 2023 | 394,000.00 |